Losmapimod (GW-856553X) is a selective, potent, and orally active p38 MAPK inhibitor.

GW5074 is a potent and selective c-Raf inhibitor.

CGP 57380 is a potent, selective MNK1 inhibitor.

IQ-1S is an effective and specific c-Jun N-Terminal Kinase Inhibitor.

Doramapimod (BIRB 796) is a pan-p38 MAPK inhibitor.

SP600125 is a broad-spectrum JNK inhibitor for JNK1, JNK2 and JNK3.

Selumetinib is a potent, highly selective MEK inhibitor with potential antineoplastic activity.

PD0325901 is an orally bioavailable, synthetic organic molecule targeting mitogen-activated protein kinase kinase with potential antineoplastic activity.